These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32290280)

  • 1. Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates.
    Lengauer H; Makuc D; Šterk D; Perdih F; Pichler A; Trdan Lušin T; Plavec J; Časar Z
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32290280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Single-Crystal Structure of Tenofovir Alafenamide Mono-Fumarate: A Metastable Phase Featuring a Mixture of Co-Crystal and Salt.
    Wang JW; Liu L; Yu KX; Bai HZ; Zhou J; Zhang WH; Hu X; Tang G
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate.
    Golla VM; Kurmi M; Shaik K; Singh S
    J Pharm Biomed Anal; 2016 Nov; 131():146-155. PubMed ID: 27589032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient.
    Mothobi NZ; Masters J; Marriott DJ
    Ther Adv Infect Dis; 2018 Sep; 5(5):91-95. PubMed ID: 30224952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resistance barrier to tenofovir alafenamide is driven by higher loading of tenofovir diphosphate into target cells compared to tenofovir disoproxil fumarate.
    Margot NA; Liu Y; Miller MD; Callebaut C
    Antiviral Res; 2016 Aug; 132():50-8. PubMed ID: 27208653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequent development of drug resistance in HIV-1-infected treatment-naive subjects after 96 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate.
    Margot N; Cox S; Das M; McCallister S; Miller MD; Callebaut C
    Antivir Ther; 2017; 22(5):443-446. PubMed ID: 28076335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.
    Buti M; Riveiro-Barciela M; Esteban R
    J Infect Dis; 2017 Nov; 216(suppl_8):S792-S796. PubMed ID: 29156043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures.
    Stray KM; Park Y; Babusis D; Callebaut C; Cihlar T; Ray AS; Perron M
    Antiviral Res; 2017 Apr; 140():116-120. PubMed ID: 28131805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity.
    Walti LN; Steinrücken J; Rauch A; Wandeler G
    Open Forum Infect Dis; 2018 Nov; 5(11):ofy275. PubMed ID: 30515426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal Structure Analysis of the First Discovered Stability-Enhanced Solid State of Tenofovir Disoproxil Free Base Using Single Crystal X-ray Diffraction.
    An JH; Kiyonga AN; Yoon W; Ryu HC; Kim JS; Kang C; Park M; Yun H; Jung K
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28708115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials.
    Hagins D; Orkin C; Daar ES; Mills A; Brinson C; DeJesus E; Post FA; Morales-Ramirez J; Thompson M; Osiyemi O; Rashbaum B; Stellbrink HJ; Martorell C; Liu H; Liu YP; Porter D; Collins SE; SenGupta D; Das M
    HIV Med; 2018 Nov; 19(10):724-733. PubMed ID: 30101539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate.
    Simpson SM; Widanapathirana L; Su JT; Sung S; Watrous D; Qiu J; Pearson E; Evanoff A; Karunakaran D; Chacon JE; Kiser PF
    Pharm Res; 2020 Apr; 37(4):83. PubMed ID: 32296951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide.
    Lalley-Chareczko L; Hiserodt E; Moorthy G; Zuppa A; Mounzer K; Koenig H
    Front Pharmacol; 2020; 11():286. PubMed ID: 32265700
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute Kidney Injury in a Patient on Tenofovir Alafenamide Fumarate After Initiation of Treatment for Hepatitis C Virus Infection.
    Serota DP; Franch HA; Cartwright EJ
    Open Forum Infect Dis; 2018 Aug; 5(8):ofy189. PubMed ID: 30151414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epi-TAF for Tenofovir Disoproxil Fumarate?
    Walensky RP; Horn TH; Paltiel AD
    Clin Infect Dis; 2016 Apr; 62(7):915-8. PubMed ID: 26658300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence.
    Byrne R; Carey I; Agarwal K
    Therap Adv Gastroenterol; 2018; 11():1756284818786108. PubMed ID: 30034532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare emergence of drug resistance in HIV-1 treatment-naïve patients receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for 144 weeks.
    Margot N; Cox S; Das M; McCallister S; Miller MD; Callebaut C
    J Clin Virol; 2018 Jun; 103():37-42. PubMed ID: 29627709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emtricitabine + tenofovir alafenamide for the treatment of HIV.
    Corado KC; Daar ES
    Expert Opin Pharmacother; 2017 Mar; 18(4):427-432. PubMed ID: 28151023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed dose darunavir boosted with cobicistat combined with emtricitabine and tenofovir alafenamide fumarate.
    Cevik M; Orkin C
    Curr Opin HIV AIDS; 2018 Jul; 13(4):315-319. PubMed ID: 29528852
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.